Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure.
Lotz GP, Lutz A, Martin-Facklam M, Hansbauer A, Schick E, Moessner E, Antony M, Stuchly T, Viert M, Hosse RJ, Freimoser-Grundschober A, Klein C, Schäfer M, Ritter M, Stubenrauch KG.
Lotz GP, et al. Among authors: hosse rj.
Front Immunol. 2024 May 31;15:1406353. doi: 10.3389/fimmu.2024.1406353. eCollection 2024.
Front Immunol. 2024.
PMID: 38881900
Free PMC article.
Clinical Trial.